The education of new investigators is essential to our progress in the prevention, detection, diagnosis, and treatment of cancer. This application seeks renewal of funding for the Tumor Biology Interdisciplinary training program at Georgetown University that has been funded by NCI since 1996. Our program has become the premier graduate and postdoctoral training program at Georgetown University Medical Center (GUMC). Its major focus is to provide predoctoral and postdoctoral trainees with lifelong multidisciplinary skills that will enable them to make significant contributions in the eradication of human cancer and to interact productively in their future with clinicians and clinical research programs. The structure of the program is integrated into the strengths of the Lombardi Comprehensive Cancer Center (LCCC), an NCI-designated comprehensive cancer center at GUMC. LCCC provides the platform for the program, stimulating interdisciplinary collaborations, offering a forum for communication and discussion of research and extensive core facilities to support research. State-of-the-art cancer research training is available in the laboratories of the participating faculty, while formal courses, seminars, journal clubs, and special interest group meetings contribute to a distinctly interdisciplinary educational experience for pre- and postdoctoral fellows. Our faculty have developed more than a dozen cancer-specific courses for this training program, and continue to create more. Significant exposure to clinical concepts is through courses, involvement in weekly clinical conferences, and seminars that focus on translational cancer research. We have received many outstanding applicants, and we have filled all slots annually and many of our past trainees have gone on to prestigious faculty positions. Recruitment of under represented minorities (URM) has been successful and several of our URM trainees are now in faculty positions in academia. The continued support of this Program will allow us to maintain our mission of focused, high quality mentorship for initiation of careers of successful new investigators, by further improving our excellent track record of academic productivity in training translational cancer biologists.

Public Health Relevance

(Seeinstructions): The education of new investigators is essential to our progress in the prevention, detection, diagnosis, and treatment of cancer. This training program is to provide predoctoral and postdoctoral trainees with lifelong multidisciplinary skills that will enable them to make significant contributions in the eradication of human cancer and to interact productively in their future in a clinical cancer research environment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009686-16
Application #
8271312
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
1996-07-01
Project End
2014-05-31
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
16
Fiscal Year
2012
Total Cost
$466,626
Indirect Cost
$32,655
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lelo, Alana; Prip, Frederik; Harris, Brent T et al. (2018) STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer. Clin Cancer Res 24:4145-4153
Stires, Hillary; Heckler, Mary M; Fu, Xiaoyong et al. (2018) Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities. Mol Cell Endocrinol 471:105-117
Vera, Nicholas B; Chen, Zhidan; Pannkuk, Evan et al. (2018) Differential mobility spectrometry (DMS) reveals the elevation of urinary acetylcarnitine in non-human primates (NHPs) exposed to radiation. J Mass Spectrom 53:548-559
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Tiek, D M; Rone, J D; Graham, G T et al. (2018) Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma. Sci Rep 8:7222
Tassi, Elena; Lai, En Yin; Li, Lingli et al. (2018) Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor-Binding Protein). Hypertension 71:160-167
Speidell, Andrew P; Demby, Tamar; Lee, Yichien et al. (2018) Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy. Neurotox Res :
Pannkuk, Evan L; Laiakis, Evagelia C; Fornace Jr, Albert J et al. (2018) A Metabolomic Serum Signature from Nonhuman Primates Treated with a Radiation Countermeasure, Gamma-tocotrienol, and Exposed to Ionizing Radiation. Health Phys 115:3-11
Parodi, Daniela A; Greenfield, Morgan; Evans, Claire et al. (2017) Alteration of Mammary Gland Development and Gene Expression by In Utero Exposure to Cadmium. Int J Mol Sci 18:
Pannkuk, Evan L; Laiakis, Evagelia C; Singh, Vijay K et al. (2017) Lipidomic Signatures of Nonhuman Primates with Radiation-Induced Hematopoietic Syndrome. Sci Rep 7:9777

Showing the most recent 10 out of 214 publications